Home › Multiple Myeloma › Nebraska › Omaha
Multiple Myeloma clinical trials in Omaha, NE
16 studies for Multiple Myeloma are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 3
- Nebraska Cancer Specialists, Omaha
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RecruitingPhase 3
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- University of Nebraska Medical Center, Omaha
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
RecruitingPhase 1/2
- Nebraska Cancer Institute, Omaha
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Recruiting
- University of Nebraska Medical Center, Omaha
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RecruitingPhase 1
- University of Nebraska, Omaha
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
RecruitingPhase 2
- University of Nebraska Medical Center, Omaha
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
Recruiting
- Unversity of Nebraska Medical Center, Omaha
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
RecruitingPhase 1
- University Of Nebraska Medical Center, Omaha
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497, Omaha
Halt Aging in Survivors of Blood Cancers
Recruiting
- University of Nebraska Medical Center, Omaha
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- and 1 more
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RecruitingPhase 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- and 1 more
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
RecruitingPhase 2
- Nebraska Cancer Specialists, Omaha
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- St. Louis, MO23 studies
- Rochester, MN23 studies
- Baldwin Park, CA23 studies
- Washington, DC22 studies
Other studies in Omaha
- Prostate Cancer28 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer19 studies
- Ovarian Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
- Metastatic Cancer14 studies
- Pancreatic Cancer14 studies
- Heart Failure13 studies
- Lung Cancer13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.